Meyka Pro banner
iRhythm Technologies, Inc.

iRhythm Technologies, Inc. Fundamental Analysis (NASDAQ: IRTC)

IRTC●NASDAQ
HealthcareMedical - Devices
$88.73
$1.49(1.65%)
U.S. Market opens in 15h 50m

iRhythm Technologies, Inc. Fundamental Analysis (NASDAQ: IRTC)

iRhythm Technologies, Inc. (NASDAQ: IRTC) shows moderate financial fundamentals with a PE ratio of -77.10, profit margin of -4.52%, and ROE of -22.80%. The company generates $0.9B in annual revenue with strong year-over-year growth of 26.24%.

Key Strengths

Cash Position19.08%
PEG Ratio0.29
Current Ratio3.57

Areas of Concern

ROE-22.80%
Operating Margin-4.47%
We analyze IRTC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 4.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
4.1/100

We analyze IRTC's fundamental strength across five key dimensions:

Efficiency Score

Weak

IRTC struggles to generate sufficient returns from assets.

ROA > 10%
-3.54%

Valuation Score

Excellent

IRTC trades at attractive valuation levels.

PE < 25
-77.10
PEG Ratio < 2
0.29

Growth Score

Excellent

IRTC delivers strong and consistent growth momentum.

Revenue Growth > 5%
26.24%
EPS Growth > 10%
61.71%

Financial Health Score

Moderate

IRTC shows balanced financial health with some risks.

Debt/Equity < 1
4.10
Current Ratio > 1
3.57

Profitability Score

Weak

IRTC struggles to sustain strong margins.

ROE > 15%
-2279.67%
Net Margin ≥ 15%
-4.52%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is IRTC Expensive or Cheap?

P/E Ratio

IRTC trades at -77.10 times earnings. This suggests potential undervaluation.

-77.10

PEG Ratio

When adjusting for growth, IRTC's PEG of 0.29 indicates potential undervaluation.

0.29

Price to Book

The market values iRhythm Technologies, Inc. at 16.86 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

16.86

EV/EBITDA

Enterprise value stands at 2894.39 times EBITDA. This signals the market has high growth expectations.

2894.39

How Well Does IRTC Make Money?

Net Profit Margin

For every $100 in sales, iRhythm Technologies, Inc. keeps $-4.52 as profit after all expenses.

-4.52%

Operating Margin

Core operations generate -4.47 in profit for every $100 in revenue, before interest and taxes.

-4.47%

ROE

Management delivers $-22.80 in profit for every $100 of shareholder equity.

-22.80%

ROA

iRhythm Technologies, Inc. generates $-3.54 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.54%

Following the Money - Real Cash Generation

Operating Cash Flow

iRhythm Technologies, Inc. generates limited operating cash flow of $55.33M, signaling weaker underlying cash strength.

$55.33M

Free Cash Flow

iRhythm Technologies, Inc. generates weak or negative free cash flow of $7.35M, restricting financial flexibility.

$7.35M

FCF Per Share

Each share generates $0.22 in free cash annually.

$0.22

FCF Yield

IRTC converts 0.25% of its market value into free cash.

0.25%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-77.10

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.29

vs 25 benchmark

P/B Ratio

Price to book value ratio

16.86

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.48

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.10

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.57

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.23

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

-0.04

vs 25 benchmark

How IRTC Stacks Against Its Sector Peers

MetricIRTC ValueSector AveragePerformance
P/E Ratio-77.1030.84 Better (Cheaper)
ROE-22.80%573.00% Weak
Net Margin-4.52%5349.00% Weak
Debt/Equity4.10-0.03 (disorted) Distorted
Current Ratio3.575.76 Strong Liquidity
ROA-3.54%-254.00% (disorted) Weak

IRTC outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews iRhythm Technologies, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

144.35%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

11.85%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

609.67%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ